Neelam Kapse
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Neelam Kapse has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Prashant Kamalakar Dhakephalkar
Bioenergy Group, MACS-Agharkar Research Institute, G.G. Agarkar Road, Pune 411004, Maharashtra, India
8 shared publications - Deepa Shetty
Bioenergy Group, MACS-Agharkar Research Institute, G.G. Agarkar Road, Pune 411004, Maharashtra, India
4 shared publications - Shilpa Wagh
Hi Tech BioSciences India Ltd., Research & Development Center, Plot No. 6 and 8, Ambadvet Industrial Estate, PO Paud, Pune 412108, Maharashtra, India
4 shared publications - Sumit Singh Dagar
Bioenergy Group, MACS-Agharkar Research Institute, G.G. Agarkar Road, Pune 411004, Maharashtra, India
4 shared publications - Prajakta Margale
Bioenergy Group, MACS-Agharkar Research Institute, G.G. Agarkar Road, Pune 411004, Maharashtra, India
3 shared publications - Tanisha Dhakephalkar
Hi Tech BioSciences India Ltd., Research & Development Centre, Plot No. 6 and 8, Ambadvet Industrial Estate, PO Paud, Pune 412108, Maharashtra, India
3 shared publications
Latest Publications
- Open Access
A Human-Derived Putative Probiotic, Ligilactobacillus salivarius MCC0226 with Adhesion, Antipathogenic, and Epithelial Gene-Modulatory Properties
Ligilactobacillus salivarius is a well-recognized probiotic species; however, the mechanisms by which individual strains contribute to gut ecosystem homeostasis and protection of the intestinal epithelial barrier remain poorly understood. This study comprehensively characterized a human-derived L. salivarius MCC0226 using an integrated genomic and functional approach to evaluate its probiotic potential. Whole-genome sequencing identified genes associated with acid and bile tolerance, adhesion, exopolysaccharide biosynthesis, oxidative stress response, bacteriocin production, bile salt hydrolase activity, and amino acid biosynthesis. At the same time, genomic safety analysis confirmed the absence of virulence factors and clinically relevant transferable antimicrobial resistance determinants. MCC0226 exhibited high survival under simulated gastric and intestinal conditions, produced 0.64 g L−1 exopolysaccharides, and showed strong adhesion to HT-29 and Caco-2 intestinal epithelial cells. The strain demonstrated broad-spectrum antimicrobial activity against 13 clinically relevant pathogens, reduced adhesion of Salmonella Typhimurium and Clostridioides difficile on HT-29 cells, co-aggregated with enteric pathogens, and produced hydrogen peroxide. Functional metabolite analysis revealed antioxidant activity, cholesterol assimilation under simulated intestinal and colonic conditions, positive bile salt hydrolase activity, and production of lactic, acetic, and butyric acids during inulin fermentation. Furthermore, MCC0226 significantly modulated the expression of epithelial junction-associated genes in HT-29 cells, including OCLN, CLDN3, CDH1, and CLDN2, while ZO-1 remained essentially unaffected. The combined genomic and in vitro evidence indicates that MCC0226 possesses multiple complementary mechanisms supporting intestinal colonization, microbial modulation, and regulation of epithelial junction-associated gene expression, highlighting its potential as a multifunctional probiotic candidate for functional food and nutraceutical applications.
Open AccessA Human-Derived Putative Probiotic, Ligilactobacillus salivarius MCC0226 with Adhesion, Antipathogenic, and Epithelial Gene-Modulatory Properties
Ligilactobacillus salivarius is a well-recognized probiotic species; however, the mechanisms by which individual strains contribute to gut ecosystem homeostasis and protection of the intestinal epithelial barrier remain poorly understood. This study comprehensively characterized a human-derived L. salivarius MCC0226 using an integrated genomic and functional approach to evaluate its probiotic potential. Whole-genome sequencing identified genes associated with acid and bile tolerance, adhesion, exopolysaccharide biosynthesis, oxidative stress response, bacteriocin production, bile salt hydrolase activity, and amino acid biosynthesis. At the same time, genomic safety analysis confirmed the absence of virulence factors and clinically relevant transferable antimicrobial resistance determinants. MCC0226 exhibited high survival under simulated gastric and intestinal conditions, produced 0.64 g L−1 exopolysaccharides, and showed strong adhesion to HT-29 and Caco-2 intestinal epithelial cells. The strain demonstrated broad-spectrum antimicrobial activity against 13 clinically relevant pathogens, reduced adhesion of Salmonella Typhimurium and Clostridioides difficile on HT-29 cells, co-aggregated with enteric pathogens, and produced hydrogen peroxide. Functional metabolite analysis revealed antioxidant activity, cholesterol assimilation under simulated intestinal and colonic conditions, positive bile salt hydrolase activity, and production of lactic, acetic, and butyric acids during inulin fermentation. Furthermore, MCC0226 significantly modulated the expression of epithelial junction-associated genes in HT-29 cells, including OCLN, CLDN3, CDH1, and CLDN2, while ZO-1 remained essentially unaffected. The combined genomic and in vitro evidence indicates that MCC0226 possesses multiple complementary mechanisms supporting intestinal colonization, microbial modulation, and regulation of epithelial junction-associated gene expression, highlighting its potential as a multifunctional probiotic candidate for functional food and nutraceutical applications.
- 15 November 2025
- Published by Springer Nature in Probiotics and Antimicrobial Proteins
- Vol. 18 (4) , 5611-5631
Functional and Genomic Insights into Clostridium butyricum MCC0233: Probiotic Features and Safety Assessment
The growing limitations of conventional probiotics have driven interest in next-generation probiotics (NGPs), with Clostridium butyricum emerging as a promising candidate due to its spore-forming nature, metabolic adaptability, and therapeutic potential. This study presents a comprehensive characterization of C. butyricum MCC0233, focusing on its probiotic functionality, genomic attributes, and safety profile. In vitro assays revealed significant resilience of MCC0233 to gastrointestinal stress, retaining 20% viability after 2 h in simulated gastric fluid and 87.9% after 6 h in simulated intestinal fluid. MCC0233 demonstrated strong adhesion to intestinal epithelial cells, 143 ± 4 bacterial cells per 100 HT-29 cells and 241 ± 1 bacterial cells per 100 Caco-2 cells. The strain exhibited high antioxidant activity (82.91%) and significant cholesterol assimilation (67.02%), which is the first report of this property in C. butyricum. It also showed broad-spectrum antimicrobial activity and effective co-aggregation with various enteric pathogens. The whole-genome sequencing revealed a 4.62 Mbp genome with 4,151 protein-coding genes and a GC content of 28.8%. Functional annotation identified genes linked to probiotic traits, including those involved in butyrate production, biosynthesis of branched-chain and aromatic amino acids, and folate (vitamin B9) synthesis. Comparative genomics highlighted strain-specific features contributing to its functional potential. Importantly, both in vitro and in silico safety assessments confirmed the absence of transferable antimicrobial resistance genes, virulence factors, or plasmids. These findings establish C. butyricum MCC0233 as a robust, safe, and multifunctional next-generation probiotic candidate, with promising applications in gut health, metabolic regulation, and microbial therapeutics.
- 15 November 2025
- Published by Springer Nature in Probiotics and Antimicrobial Proteins
- Vol. 18 (4) , 5611-5631
Functional and Genomic Insights into Clostridium butyricum MCC0233: Probiotic Features and Safety Assessment
The growing limitations of conventional probiotics have driven interest in next-generation probiotics (NGPs), with Clostridium butyricum emerging as a promising candidate due to its spore-forming nature, metabolic adaptability, and therapeutic potential. This study presents a comprehensive characterization of C. butyricum MCC0233, focusing on its probiotic functionality, genomic attributes, and safety profile. In vitro assays revealed significant resilience of MCC0233 to gastrointestinal stress, retaining 20% viability after 2 h in simulated gastric fluid and 87.9% after 6 h in simulated intestinal fluid. MCC0233 demonstrated strong adhesion to intestinal epithelial cells, 143 ± 4 bacterial cells per 100 HT-29 cells and 241 ± 1 bacterial cells per 100 Caco-2 cells. The strain exhibited high antioxidant activity (82.91%) and significant cholesterol assimilation (67.02%), which is the first report of this property in C. butyricum. It also showed broad-spectrum antimicrobial activity and effective co-aggregation with various enteric pathogens. The whole-genome sequencing revealed a 4.62 Mbp genome with 4,151 protein-coding genes and a GC content of 28.8%. Functional annotation identified genes linked to probiotic traits, including those involved in butyrate production, biosynthesis of branched-chain and aromatic amino acids, and folate (vitamin B9) synthesis. Comparative genomics highlighted strain-specific features contributing to its functional potential. Importantly, both in vitro and in silico safety assessments confirmed the absence of transferable antimicrobial resistance genes, virulence factors, or plasmids. These findings establish C. butyricum MCC0233 as a robust, safe, and multifunctional next-generation probiotic candidate, with promising applications in gut health, metabolic regulation, and microbial therapeutics.
- 18 September 2025
- Published by Springer Nature in Archives of Microbiology
- Vol. 207 (11) , 1-16
Probing the adhesion potential of Bifidobacterium animalis subsp. lactis MCM-B-2007 via in vitro and in silico analyses
Bifidobacterium strains are widely recognized for their probiotic properties, and their ability to adhere to the intestinal epithelium is crucial for effective gut colonization and interaction with the host. This study offers a thorough examination of the adhesion capabilities of Bifidobacterium animalis subsp. lactis, integrating in silico analyses with in vitro adhesion assessments. Genome analysis of MCM-B-2007 identified several adhesion proteins that might act as potential mediators of crosstalk between microbes and their host. Molecular docking studies further assessed these adhesion proteins interaction with gut mucins. MCM-B-2007 displayed the highest affinity for binding to MUC4, with a predicted weighted score of -1539.5. These adhesion capabilities were subsequently validated through in vitro adhesion assays. MCM-B-2007 demonstrated a significant adhesion potential, with an adhesion efficiency of approximately 306 ± 20 bacterial cells per 100 HT-29 cells, classifying it as a strongly adhesive strain. Additionally, MCM-B-2007 demonstrated the strong competitive inhibition of adhesion of pathogenic Klebsiella pneumoniae and Salmonella Typhimurium, effectively safeguarding the host cells against infections. These findings support its use as a probiotic with the potential for future application in establishing healthy gut microbiota.
- 18 September 2025
- Published by Springer Nature in Archives of Microbiology
- Vol. 207 (11) , 1-16
Probing the adhesion potential of Bifidobacterium animalis subsp. lactis MCM-B-2007 via in vitro and in silico analyses
Bifidobacterium strains are widely recognized for their probiotic properties, and their ability to adhere to the intestinal epithelium is crucial for effective gut colonization and interaction with the host. This study offers a thorough examination of the adhesion capabilities of Bifidobacterium animalis subsp. lactis, integrating in silico analyses with in vitro adhesion assessments. Genome analysis of MCM-B-2007 identified several adhesion proteins that might act as potential mediators of crosstalk between microbes and their host. Molecular docking studies further assessed these adhesion proteins interaction with gut mucins. MCM-B-2007 displayed the highest affinity for binding to MUC4, with a predicted weighted score of -1539.5. These adhesion capabilities were subsequently validated through in vitro adhesion assays. MCM-B-2007 demonstrated a significant adhesion potential, with an adhesion efficiency of approximately 306 ± 20 bacterial cells per 100 HT-29 cells, classifying it as a strongly adhesive strain. Additionally, MCM-B-2007 demonstrated the strong competitive inhibition of adhesion of pathogenic Klebsiella pneumoniae and Salmonella Typhimurium, effectively safeguarding the host cells against infections. These findings support its use as a probiotic with the potential for future application in establishing healthy gut microbiota.
- Open Access
- 27 August 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (9) , 1771
Strain-Dependent Adhesion Variations of Shouchella clausii Isolated from Healthy Human Volunteers: A Study on Cell Surface Properties and Potential Probiotic Benefits
The probiotic potential of Shouchella clausii is widely recognized, but little is known about its adhesive properties. Hence, this study aims to investigate the adhesion potential and cell surface properties of four human-origin S. clausii strains (B619/R, B603/Nb, B106, and B637/Nm). We evaluated epithelial adhesion, Extracellular Matrix (ECM) binding, aggregation ability, and cell surface hydrophobicity and used genome analysis for validation. Our results demonstrate that adhesion capability is a strain-specific attribute, with significant variations observed among the four strains. B619/R, B603/Nb, and B106 displayed stronger adhesion properties than B637/Nm. Supplementary adhesion assays showed that B637/Nm displayed high hydrophobicity, significant auto-aggregation, and significant mucin-binding abilities. Conversely, B619/R, B603/Nb, and B106 had mildly hydrophobic surfaces and low aggregation abilities. Genome annotation revealed the presence of various adhesion proteins in four strains. Notably, the reduced adhesion potential of B637/Nm was supported by the absence of the cell wall surface anchor family protein (LPxTG motif), which is crucial for interactions with intestinal epithelial cells or mucus components. Further, docking studies provided insights into the interaction of adhesion proteins with gut mucins. These findings contribute to a better understanding of how S. clausii strains interact with the gut environment, facilitating the development of probiotic formulations tailored for improved gut health and well-being.
- 27 August 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (9) , 1771
Open AccessStrain-Dependent Adhesion Variations of Shouchella clausii Isolated from Healthy Human Volunteers: A Study on Cell Surface Properties and Potential Probiotic Benefits
The probiotic potential of Shouchella clausii is widely recognized, but little is known about its adhesive properties. Hence, this study aims to investigate the adhesion potential and cell surface properties of four human-origin S. clausii strains (B619/R, B603/Nb, B106, and B637/Nm). We evaluated epithelial adhesion, Extracellular Matrix (ECM) binding, aggregation ability, and cell surface hydrophobicity and used genome analysis for validation. Our results demonstrate that adhesion capability is a strain-specific attribute, with significant variations observed among the four strains. B619/R, B603/Nb, and B106 displayed stronger adhesion properties than B637/Nm. Supplementary adhesion assays showed that B637/Nm displayed high hydrophobicity, significant auto-aggregation, and significant mucin-binding abilities. Conversely, B619/R, B603/Nb, and B106 had mildly hydrophobic surfaces and low aggregation abilities. Genome annotation revealed the presence of various adhesion proteins in four strains. Notably, the reduced adhesion potential of B637/Nm was supported by the absence of the cell wall surface anchor family protein (LPxTG motif), which is crucial for interactions with intestinal epithelial cells or mucus components. Further, docking studies provided insights into the interaction of adhesion proteins with gut mucins. These findings contribute to a better understanding of how S. clausii strains interact with the gut environment, facilitating the development of probiotic formulations tailored for improved gut health and well-being.
- Open Access
- 4 July 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-12
Appropriate characterization of reservoir properties and investigation of their effect on microbial enhanced oil recovery through simulated laboratory studies
Appropriate characterization of reservoir properties and investigation of the effect of these properties on microbial metabolism and oil recovery under simulated reservoir conditions can aid in development of a sustainable microbial enhanced oil recovery (MEOR) process. Our present study has unveiled the promising potential of the hyperthermophilic archaeon, identified as Thermococcus petroboostus sp. nov. 101C5, to positively influence the microenvironment within simulated oil reservoirs, by producing significant amounts of metabolites, such as biosurfactants, biopolymers, biomass, acids, solvents, gases. These MEOR desired metabolites were found to cause a series of desirable changes in the physicochemical properties of crude oil and reservoir rocks, thereby enhancing oil recovery. Furthermore, our study demonstrated that the microbial activity of 101C5 led to the mobilization of crude oil, consequently resulting in enhanced production rates and increased efficiency in simulated sand pack trials. 101C5 exhibited considerable potential as a versatile microorganism for MEOR applications across diverse reservoir conditions, mediating significant light as well as heavy oil recovery from Berea/carbonaceous nature of rock bearing intergranular/vugular/fracture porosity at extreme reservoir conditions characterized by high temperature (80–101 °C) and high pressure (700–1300 psi). Core flood study, which truly mimicked the reservoir conditions demonstrated 29.5% incremental oil recovery by 101C5 action from Berea sandstone at 900 psi and 96 °C, underscoring the potential of strain 101C5 for application in the depleted high temperature oil wells.
- 4 July 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-12
Open AccessAppropriate characterization of reservoir properties and investigation of their effect on microbial enhanced oil recovery through simulated laboratory studies
Appropriate characterization of reservoir properties and investigation of the effect of these properties on microbial metabolism and oil recovery under simulated reservoir conditions can aid in development of a sustainable microbial enhanced oil recovery (MEOR) process. Our present study has unveiled the promising potential of the hyperthermophilic archaeon, identified as Thermococcus petroboostus sp. nov. 101C5, to positively influence the microenvironment within simulated oil reservoirs, by producing significant amounts of metabolites, such as biosurfactants, biopolymers, biomass, acids, solvents, gases. These MEOR desired metabolites were found to cause a series of desirable changes in the physicochemical properties of crude oil and reservoir rocks, thereby enhancing oil recovery. Furthermore, our study demonstrated that the microbial activity of 101C5 led to the mobilization of crude oil, consequently resulting in enhanced production rates and increased efficiency in simulated sand pack trials. 101C5 exhibited considerable potential as a versatile microorganism for MEOR applications across diverse reservoir conditions, mediating significant light as well as heavy oil recovery from Berea/carbonaceous nature of rock bearing intergranular/vugular/fracture porosity at extreme reservoir conditions characterized by high temperature (80–101 °C) and high pressure (700–1300 psi). Core flood study, which truly mimicked the reservoir conditions demonstrated 29.5% incremental oil recovery by 101C5 action from Berea sandstone at 900 psi and 96 °C, underscoring the potential of strain 101C5 for application in the depleted high temperature oil wells.
- Open Access
- 7 February 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (2) , 347
Unveiling the Probiotic Potential of Streptococcus thermophilus MCC0200: Insights from In Vitro Studies Corroborated with Genome Analysis
Streptococcus thermophilus is widely used as a starter culture in the dairy industry and has garnered attention as a beneficial bacterium owing to its health-promoting functionalities in humans. In this study, the probiotic potential of S. thermophilus MCC0200 isolated from a dairy product was investigated through a combinatorial approach of in vitro and in silico studies. MCC0200 demonstrated the ability to survive harsh gastrointestinal (GI) transit, adhere to intestinal mucosa and exert health-promoting traits in in vitro studies. These findings were corroborated with in silico evidence, wherein, MCC0200 genome harboured genes associated with tolerance to GI conditions, intestinal adhesion and colonization. Genome mapping also highlighted the ability of MCC0200 to produce compounds advantageous for the host (folate, bacteriocins), to release antioxidant enzymes that can quench the free radicals (superoxide dismutase, NADH peroxidase), and to metabolize food components that can be harmful to sensitive people (lactose). MCC0200 also demonstrated a positive effect on reducing cholesterol levels, proving to be a potential candidate for food and pharmaceutical applications. The absence of transmissible antibiotic resistance genes and virulence genes underscored the generally regarded as safe (GRAS) nature of MCC0200. This study explored the potential of Streptococcus thermophilus for its probable applications as a probiotic beyond the dairy industry.
- 7 February 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (2) , 347
Open AccessUnveiling the Probiotic Potential of Streptococcus thermophilus MCC0200: Insights from In Vitro Studies Corroborated with Genome Analysis
Streptococcus thermophilus is widely used as a starter culture in the dairy industry and has garnered attention as a beneficial bacterium owing to its health-promoting functionalities in humans. In this study, the probiotic potential of S. thermophilus MCC0200 isolated from a dairy product was investigated through a combinatorial approach of in vitro and in silico studies. MCC0200 demonstrated the ability to survive harsh gastrointestinal (GI) transit, adhere to intestinal mucosa and exert health-promoting traits in in vitro studies. These findings were corroborated with in silico evidence, wherein, MCC0200 genome harboured genes associated with tolerance to GI conditions, intestinal adhesion and colonization. Genome mapping also highlighted the ability of MCC0200 to produce compounds advantageous for the host (folate, bacteriocins), to release antioxidant enzymes that can quench the free radicals (superoxide dismutase, NADH peroxidase), and to metabolize food components that can be harmful to sensitive people (lactose). MCC0200 also demonstrated a positive effect on reducing cholesterol levels, proving to be a potential candidate for food and pharmaceutical applications. The absence of transmissible antibiotic resistance genes and virulence genes underscored the generally regarded as safe (GRAS) nature of MCC0200. This study explored the potential of Streptococcus thermophilus for its probable applications as a probiotic beyond the dairy industry.
- Open Access
- 7 December 2023
- Published by MDPI AG in Preprints.org
Unveiling the Probiotic Potential of Streptococcus thermophilus MCC0200: Insights from In-vitro Studies corroborated with Genome Analysis
Streptococcus thermophilus is widely used as a starter culture in the dairy industry and has garnered attention as a beneficial bacterium owing to its health-promoting functionalities in humans. In this study, the probiotic potential of S. thermophilus MCC0200, isolated from a dairy product, was investigated through a combinatorial approach of in-vitro and in-silico studies. MCC0200 demonstrated the ability to survive harsh gastro-intestinal transit (GIT), adhere to intestinal mucosa and exert health-promoting traits in in-vitro studies. These findings were corroborated with in-silico evidence, wherein MCC0200 genome harboured genes associated with tolerance to GIT conditions, intestinal adhesion and colonization. Genome mapping also highlighted the ability of MCC0200 to produce compounds advantageous for host (folate, bacteriocins), to release enzymes that can reinforce the host ability (antioxidative enzymes), to metabolize food components that can be harmful to sensitive people (lactose). MCC0200 also demonstrated a positive effect on reducing cholesterol levels, proving to be a potential candidate for food and pharmaceutical applications. Absence of transmissible antibiotic resistance genes and virulence genes underscored the GRAS nature of MCC0200. This study explored the potential of Streptococcus thermophilus for its probable applications as a probiotic beyond the dairy industry.
- 7 December 2023
- Published by MDPI AG in Preprints.org
Open AccessUnveiling the Probiotic Potential of Streptococcus thermophilus MCC0200: Insights from In-vitro Studies corroborated with Genome Analysis
Streptococcus thermophilus is widely used as a starter culture in the dairy industry and has garnered attention as a beneficial bacterium owing to its health-promoting functionalities in humans. In this study, the probiotic potential of S. thermophilus MCC0200, isolated from a dairy product, was investigated through a combinatorial approach of in-vitro and in-silico studies. MCC0200 demonstrated the ability to survive harsh gastro-intestinal transit (GIT), adhere to intestinal mucosa and exert health-promoting traits in in-vitro studies. These findings were corroborated with in-silico evidence, wherein MCC0200 genome harboured genes associated with tolerance to GIT conditions, intestinal adhesion and colonization. Genome mapping also highlighted the ability of MCC0200 to produce compounds advantageous for host (folate, bacteriocins), to release enzymes that can reinforce the host ability (antioxidative enzymes), to metabolize food components that can be harmful to sensitive people (lactose). MCC0200 also demonstrated a positive effect on reducing cholesterol levels, proving to be a potential candidate for food and pharmaceutical applications. Absence of transmissible antibiotic resistance genes and virulence genes underscored the GRAS nature of MCC0200. This study explored the potential of Streptococcus thermophilus for its probable applications as a probiotic beyond the dairy industry.
- Open Access
- 20 April 2021
- Published by MDPI AG in Sustainability
- Vol. 13 (8) , 4590
Comparative Genomic Analysis of Arctic Permafrost Bacterium Nesterenkonia sp. PF2B19 to Gain Insights into Its Cold Adaptation Tactic and Diverse Biotechnological Potential
Nesterenkonia sp. PF2B19, a psychrophile was isolated from 44,800-year-old permafrost soil. This is the first report on comparative genomics of Nesterenkonia sp. isolated from Arctic. Genome of PF2B19 exhibited the presence of a vast array of genetic determinants involved in cold adaptation i.e., response to cold-associated general, osmotic, and oxidative stress. These genomic attributes proved to be valuable in unraveling the adaptive tactics employed by PF2B19 for survival in the cold permafrost soils of the Arctic. Genomic analysis of PF2B19 has given some valuable insight into the biotechnological potential of this strain, particularly as a source of cold-active enzymes, as a bioremediating agent and as plant growth-promoting bacteria.
- 20 April 2021
- Published by MDPI AG in Sustainability
- Vol. 13 (8) , 4590
Open AccessComparative Genomic Analysis of Arctic Permafrost Bacterium Nesterenkonia sp. PF2B19 to Gain Insights into Its Cold Adaptation Tactic and Diverse Biotechnological Potential
Nesterenkonia sp. PF2B19, a psychrophile was isolated from 44,800-year-old permafrost soil. This is the first report on comparative genomics of Nesterenkonia sp. isolated from Arctic. Genome of PF2B19 exhibited the presence of a vast array of genetic determinants involved in cold adaptation i.e., response to cold-associated general, osmotic, and oxidative stress. These genomic attributes proved to be valuable in unraveling the adaptive tactics employed by PF2B19 for survival in the cold permafrost soils of the Arctic. Genomic analysis of PF2B19 has given some valuable insight into the biotechnological potential of this strain, particularly as a source of cold-active enzymes, as a bioremediating agent and as plant growth-promoting bacteria.